BLUE CROSS BLUE SHIELD OF MICHIGAN

Affordable Care Act (ACA), ACA subsidies and tax credits; Telehealth/ telehealth flexibilities; ACA Fraud; Telehealth/ telehealth flexibilities; Transparency in coverage; Surprise Billing; 2025 Proposed NBPP/Individual Market/ACA exchanges; Rural healthcare; Prior Authorization; Hospital Consolidation; Employer-provided health coverage; Cyber Attack/ Cyber Security; Managed Care Organizations; Health Equity + Maternal Health; Hospital Billing; Anti-tiering, Anti-steering; Health Equity; Program integrity in the individual marketplace; Federal Budget Process S. 1451 Healthy Competition for Better Care Act To ban anticompetitive terms in facility and insurance contracts that limit access to higher quality, lower cost care. Sponsor: Sen. Braun, Mike [R-IN] H.R.3120 - Healthy Competition for Better Care Act To ban anticompetitive terms in facility and insurance contracts that limit access to higher quality, lower cost care. Sponsor: Rep. Steel, Michelle [R-CA-45] H.R.2630 - Safe Step Act To amend the Employee Retirement Income Security Act of 1974 to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol, and for other purposes. Sponsor: Rep. Wenstrup, Brad R. [R-OH-2] S.652 - Safe Step Act To amend the Employee Retirement Income Security Act of 1974 to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol, and for other purposes. Sponsor: Sen. Murkowski, Lisa [R-AK] S. 1001 Telehealth Expansion Act of 2023 To amend the Internal Revenue Code of 1986 to permanently extend the exemption for telehealth services from certain high deductible health plan rules. Sponsor: Sen. Daines, Steve [R-MT] H.R. 1843 - Telehealth Expansion Act To amend the Internal Revenue Code of 1986 to permanently extend the exemption for telehealth services from certain high deductible health plan rules. Sponsor: Rep. Steel, Michelle [R-CA-45] S.1869 - SITE Act To amend title XVIII of the Social Security Act and title XXVII of the Public Health Service Act to ensure fair billing practice for items and services furnished by off-campus hospital locations, to amend such title XVIII to provide for payments for graduate nursing education costs, and for other purposes. Sponsor: Sen. Braun, Mike [R-IN] H.R.3417 - FAIR Act To ensure fair billing practices for items and services furnished by off-campus outpatient departments of a provider. Sponsor: Rep. Hern, Kevin [R-OK-1] H.R. 5378 Lower Costs, More Transparency Act To promote price transparency in the health care sector, and for other purposes. Sponsor: Rep. McMorris Rodgers, Cathy [R-WA-5] H.R.4531 - Support for Patients and Communities Reauthorization Act To reauthorize certain programs that provide for opioid use disorder prevention, recovery, and treatment, and for other purposes. Sponsor: Rep. Guthrie, Brett [R-KY-2] H.R.3630 - No Surprises Act To amend title XXVII of the Public Health Service Act to protect health care consumers from surprise billing practices, and for other purposes. Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6] S.2016 - CONNECT for Health Act of 2023 To amend title XVIII of the Social Security Act to expand access to telehealth services, and for other purposes. Sponsor: Sen. Schatz, Brian [D-HI] H.R. 4189, CONNECT for Health Act To amend title XVIII of the Social Security Act to expand access to telehealth services, and for other purposes. Sponsor: Rep. Thompson, Mike [D-CA-4] H.R. 10545, American Relief Act, 2025 Making further continuing appropriations for the fiscal year ending September 30, 2025, and for other purposes. Sponsor: Rep. Cole, Tom [R-OK-4] H.R. 5163 TREATS Act To amend the Controlled Substances Act to allow for the use of telehealth in substance use disorder treatment, and for other purposes. Sponsor: Rep. Trone, David J. [D-MD-6] S.3193 - TREATS Act To amend the Controlled Substances Act to allow for the use of telehealth in substance use disorder treatment, and for other purposes. Sponsor: Sen. Whitehouse, Sheldon [D-RI] S.891 - Bipartisan Health Care Act A bill to extend expiring health provisions and improve health care delivery. Sponsor: Sen. Wyden, Ron [D-OR] S.46 - Health Care Affordability Act of 2025 A bill to amend the Internal Revenue Code of 1986 to expand eligibility for the refundable credit for coverage under a qualified health plan. Sponsor: Sen. Shaheen, Jeanne [D-NH] H.R.247 - Health Care Affordability Act of 2025 To amend the Internal Revenue Code of 1986 to expand eligibility for the refundable credit for coverage under a qualified health plan. Sponsor: Rep. Underwood, Lauren [D-IL-14] H.R.3312 - Moms Matter Act This bill establishes two grant programs to address maternal mental health conditions and substance use disorders, with a focus on demographic groups with elevated rates of maternal mortality and morbidity, maternal health disparities, and other adverse outcomes. Sponsor: Rep. Blunt Rochester, Lisa [D-DE-At Large] H.R.10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 This bill provides continuing FY2025 appropriations for federal agencies and provides emergency funding for disaster relief. It also extends, modifies, or establishes various programs and authorities throughout the federal government. Sponsor: Rep. Cole, Tom [R-OK-4] H.R.3120 - Healthy Competition for Better Care Act To ban anticompetitive terms in facility and insurance contracts that limit access to higher quality, lower cost care. Sponsor: Rep. Steel, Michelle [R-CA-45] H.R.3029 - Primary Care Enhancement Act of 2023 To amend the Internal Revenue Code of 1986 to allow individuals with direct primary care service arrangements to remain eligible individuals for purposes of health savings accounts, and for other purposes. Sponsor: Rep. Smucker, Lloyd [R-PA-11]

Same-day billing restrictions in Medicaid; Medicare Advantage & MA Rate Notice; Medicare/Transparency; Medicaid Cuts; Mental Health Care, Youth Mental Health; Site neutral payment reform; Healthy Equity Index reward factor; Value Base Care H.R.5746 - Addressing Whole Health in Medicare Advantage Act To amend title XVIII of the Social Security Act to expand the availability of supplemental benefits to certain Medicare Advantage enrollees. Sponsor: Rep. Bilirakis, Gus M. [R-FL-12] H.R. 7623, Telehealth Modernization Act To amend title XVIII of the Social Security Act to make permanent certain telehealth flexibilities under the Medicare program. Sponsor: Rep. Carter, Earl L. "Buddy" [R-GA-1] S.2556 - Improving CARE for Youth Act To amend title XIX of the Social Security Act to ensure Medicaid coverage of mental health services and primary care services furnished on the same day. Sponsor: Sen. Carper, Thomas R. [D-DE] H.R.1227 - Alternatives to PAIN Act To amend title XVIII of the Social Security Act to ensure appropriate access to non-opioid pain management drugs under part D of the Medicare program. Sponsor: Rep. Miller-Meeks, Mariannette [R-IA-1] H.R.2433 - Reducing Medically Unnecessary Delays in Care Act of 2025 To ensure that prior authorization medical decisions under Medicare are determined by physicians. Sponsor: Rep. Green, Mark E. [R-TN-7]

340B Program/Transparency; generics access; Pharmacy Benefit Managers; Prescription Drug Cost; Step Therapy S. 1114, Expanding Access to Low-Cost Generics Act To amend the Federal Food, Drug, and Cosmetic Act with respect to the 180-day exclusivity period. Sponsor: Sen. Smith, Tina [D-MN] S. 2305 - Biosimilar Red Tape Elimination Act To improve the requirements for making a determination of interchangeability of a biological product and its reference product. Sponsor: Sen. Lee, Mike [R-UT] S. 775, Increasing Transparency in Generic Drug Applications To provide for increased transparency in generic drug applications. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.3839 - To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2] S. 150 - Affordable Prescriptions for Patients Act of 2023 To amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] H.R.9070 - Affordable Prescriptions for Patients Act of 2024 To amend title 35, United States Code, to prohibit product hopping, and for other purposes. Sponsor: Rep. Issa, Darrell [R-CA-48] S. 142 - Preserve Access to Affordable Generics and Biosimilars Act To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen. Klobuchar, Amy [D-MN] S. 1067, Ensuring Timely Access to Generics Act To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions. Sponsor: Sen. Shaheen, Jeanne [D-NH] S.1041 - Affordable Prescriptions for Patients Act A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1040 - Drug Competition Enhancement Act A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1096 - Preserve Access to Affordable Generics and Biosimilars Act A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen. Klobuchar, Amy [D-MN] S.1095 - Stop STALLING Act A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes. Sponsor: Sen. Klobuchar, Amy [D-MN]